Editor Profile

Neil M. Ampel, MD

Associate Editor

About the NEJM Journal Watch Infectious Diseases Board

Neil M. Ampel, MD, is Professor of Medicine and Public Health at the University of Arizona College of Medicine and Staff Physician at the Arizona Veterans Affairs Health Care System in Tucson. His clinical interests include HIV infection and fungal infections, particularly coccidioidomycosis, and his research focuses on the cellular immune response in coccidioidomycosis. Dr. Ampel is a member of the NIH/CDC/IDSA Working Group for Therapy of Opportunistic Infections and the American Thoracic Society’s Committee on the Treatment of Fungal Diseases Complicating AIDS. He is a former president of the Veterans Administration Society for Practitioners of Infectious Diseases. Dr. Ampel has been writing for NEJM Journal Watch Infectious Diseases since 2002.


Leadership positions in professional societies

Coccidioidomycosis Study Group (President-Elect)

Summaries by Neil Ampel

  • November 18, 2015

    Effect of Viral Respiratory Illness on Older Adults

    1. Neil M. Ampel, MD

    In a prospective, observational study, participants aged ≥60 with underlying illness were more likely than younger, healthy participants to have dyspnea and prolonged symptoms.

  • October 22, 2015

    Using PCR to Shorten Isolation for Patients with Suspected TB

    1. Neil M. Ampel, MD

    In a retrospective analysis, 81% of patients with culture-confirmed tuberculosis and at least three sputum samples had positive polymerase chain reaction results; 74% had positive smears.

  • October 20, 2015

    Using Experimental Pneumococcal Colonization to Test Vaccine EfficacyFree

    1. Neil M. Ampel, MD

    In a randomized, controlled, double-blind trial, colonization with the 6B serotype was reduced by 78% in adults who received the 13-valent pneumococcal conjugate vaccine.

  • October 15, 2015

    Can Genomic Biomarkers Help Diagnose Severe CAP?

    1. Neil M. Ampel, MD

    The FAIM3:PLAC8 gene-expression ratio had a positive predictive value of 83.1% and a negative predictive value of 81.3% for diagnosing CAP in intensive care unit patients.

  • September 23, 2015

    PICCs Increase Thromboembolism RiskFree

    1. Neil M. Ampel, MD

    Analysis of a large data set revealed a nearly 10.5-fold increased risk for upper-extremity deep venous thrombosis in patients with peripherally inserted intravenous catheters.

  • September 18, 2015

    Rapid Multiplex Polymerase Chain Reaction for Positive Blood CulturesFree

    1. Neil M. Ampel, MD

    In a randomized trial, use of an rmPCR assay decreased time to pathogen identification from 22 to 1.3 hours and — when combined with antimicrobial stewardship — accelerated antimicrobial de-escalation.